Aurinia Pharmaceuticals: Q3 Earnings Insights
Aurinia Pharmaceuticals (NASDAQ:AUPH) reported its Q3 earnings results on Wednesday, November 3, 2021 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Aurinia Pharmaceuticals their estimated earnings by 18.18%, reporting an EPS of $-0.39 versus an estimate of $-0.33, which surprised analysts.
Revenue was up $14,638,000 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.23, which was followed by a 23.14% increase in the share price the next day.
Here's a look at Aurinia Pharmaceuticals's past performance:
| Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.14 | -0.14 | -0.14 | -0.15 |
| EPS Actual | -0.37 | -0.40 | -0.05 | -0.28 |
| Revenue Estimate | 40.00K | 40.00K | 40.00K | 50.00K |
| Revenue Actual | 6.62M | 914.00K | 50.03M | 29.00K |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
Posted-In: BZI-RecapsEarnings News
